GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Common Stock

Celadon Pharmaceuticals (LSE:CEL) Common Stock : €0.75 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Common Stock?

Celadon Pharmaceuticals's quarterly common stock increased from Dec. 2022 (€0.71 Mil) to Jun. 2023 (€0.72 Mil) and increased from Jun. 2023 (€0.72 Mil) to Dec. 2023 (€0.75 Mil).

Celadon Pharmaceuticals's annual common stock increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.71 Mil) and increased from Dec. 2022 (€0.71 Mil) to Dec. 2023 (€0.75 Mil).

Celadon Pharmaceuticals Common Stock Historical Data

The historical data trend for Celadon Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Common Stock Chart

Celadon Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
- - - 0.71 0.75

Celadon Pharmaceuticals Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial 0.09 0.72 0.71 0.72 0.75

Celadon Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Common Stock
Comparable Companies
LSE:STX LSE:AGY LSE:EAH LSE:VLG LSE:CHLL LSE:PXS LSE:ANCR AQSE:ANA LSE:HELD LSE:N4P ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
32-33 Cowcross Street, London, GBR, EC1M 6DF
Website
https://www.celadonpharma.co.uk
Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines